People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Advanced Cardiac Therapeutics Inc | — | Pharma | Series C | $64.1M | $1.6B | 2017 |
Philippe Marco at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Philippe Marco on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ryan Drant | 1 | 24 |
| Duke Rohlen | 1 | 10 |
| Doug Koo | 1 | 8 |
| Justin Klein | 1 | 6 |
| Roy Tanaka | 1 | 6 |
| Michael Henson | 1 | 5 |
| Peter Van Der Sluis | 1 | 3 |
| William Olson | 1 | 3 |
| Aris Constantinides | 1 | 2 |
| Michael Pederson | 1 | 2 |
| Eric Kanowsky | 1 | 2 |
| Rolf Witte | 1 | 1 |
| Timothy Lenihan | 1 | 1 |
| Jon Hunt | 1 | 1 |
| Gerard Harper | 1 | 1 |
| John Milad | 1 | 1 |
| Rolf Hunt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.